Medicare Enrolled

Dr. Saravanan Balamuthusamy, M.D.

Internal Medicine · Fort Worth, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
1001 PENNSYLVANIA AVE, Fort Worth, TX 76104
8178775858
In practice since 2007 (18 years)
NPI: 1932395811 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Balamuthusamy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Balamuthusamy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Balamuthusamy

Dr. Saravanan Balamuthusamy is an internal medicine in Fort Worth, TX, with 18 years in practice. Based on federal Medicare data, Dr. Balamuthusamy performed 2,364 Medicare services across 1,513 unique beneficiaries.

Between the years covered by Open Payments, Dr. Balamuthusamy received a total of $416,399 from 45 pharmaceutical and/or device companies across 596 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Balamuthusamy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 15% volume in TX$ $416,399 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,364
Medicare services
Top 15% in TX for internal medicine
1,513
Unique beneficiaries
$179
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~131 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Home dialysis services per month (20 years or older)214$234$500
Injection, midazolam hydrochloride, per 1 mg171$0$20
Office visit, established patient (30-39 min)167$84$300
Hospital follow-up visit, high complexity158$90$400
Injection, fentanyl citrate, 0.1 mg155$1$15
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes153$39$250
Contrast dye for imaging (iodine-based)142$0$20
Ultrasound of hemodialysis access135$99$700
Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes130$9$50
Ultrasound study of arm or leg veins with compression and maneuvers93$113$800
Ultrasound of leg arteries or artery grafts88$187$700
Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist76$905$5,100
Advance care planning consultation, first 30 min73$53$300
Insertion of tube into chest or arm artery, each first order branch50$443$4,100
Ultrasound evaluation of blood vessel with review by radiologist, initial vessel49$750$2,500
Review by radiologist of arm or leg artery image49$111$700
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less46$50$300
Balloon dilation of dialysis segment with review by radiologist37$468$3,100
Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel34$134$900
Infusion, normal saline solution, sterile (500 ml = 1 unit)32$1$50
Injection, cefazolin sodium, 500 mg31$1$5
Injection for x-ray imaging procedure into vein of arm or leg29$183$1,400
Initial hospital admission, high complexity26$133$500
Insertion of needle and/or tube into hemodialysis circuit and insertion of stent in dialysis segment with review by radiologist25$3,404$23,000
Ultrasonic guidance for blood vessel access25$31$150
Insertion of needle and/or tube into hemodialysis circuit with review by radiologist24$490$2,500
Injection, lorazepam, 2 mg24$1$5
Hospital follow-up visit, moderate complexity20$62$300
Removal of tunneled central venous tube19$97$700
Fluoroscopic guidance for insertion or removal of central vein access device18$80$350
Balloon dilation of vein with review by radiologist, initial vein15$1,024$6,000
Review by radiologist of major upper body vein image15$81$600
Review by radiologist of both arms and legs veins of both arms or legs image14$92$600
Complete ultrasound of artery and vein blood flow pre-op assessment on both sides of body for hemodialysis access14$196$800
Replacement of tunneled central venous tube13$310$2,900
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.9% high complexity
55.7% medium
39.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$416,399
Total received (2018-2024)
Avg $59,486/year across 7 years
Top 0% in TX for internal medicine
45
Companies
596
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$322,909 (77.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$89,859 (21.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,631 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$83,817
2023
$111,051
2022
$70,715
2021
$25,612
2020
$19,599
2019
$75,238
2018
$30,367

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$82,304
Travere Therapeutics, Inc.
$69,254
Janssen Pharmaceuticals, Inc
$47,475
Vifor Pharma, Inc.
$40,922
Relypsa, Inc.
$40,496
Bard Peripheral Vascular, Inc.
$40,491
Horizon Therapeutics plc
$34,127
W. L. Gore & Associates, Inc.
$17,453
AstraZeneca Pharmaceuticals LP
$10,699
SOBI, INC
$8,751
GlaxoSmithKline, LLC.
$6,078
BARD PERIPHERAL VASCULAR, INC.
$5,886
Outset Medical Inc
$4,500
Merit Medical Systems Inc
$3,000
Otsuka America Pharmaceutical, Inc.
$1,634
C. R. Bard, Inc. & Subsidiaries
$900
Medtronic Vascular, Inc.
$484
Cardiovascular Systems Inc.
$216
Bayer HealthCare Pharmaceuticals Inc.
$179
Abbott Laboratories
$158
Bayer Healthcare Pharmaceuticals Inc.
$138
Boston Scientific Corporation
$125
Mallinckrodt LLC
$121
Philips Electronics North America Corporation
$112
Aurinia Pharma U.S., Inc.
$102
Medtronic, Inc.
$99
Alexion Pharmaceuticals, Inc.
$88
OPKO Pharmaceuticals, LLC
$75
NxStage Medical, Inc.
$71
CorMedix Inc.
$59
Tactile Systems Technology Inc
$52
Ultragenyx Pharmaceutical Inc.
$42
Fresenius USA Marketing, Inc.
$40
AKEBIA THERAPEUTICS INC
$36
AngioDynamics, Inc.
$34
CashFlow Solutions, LLC
$26
Calliditas Therapeutics US Inc.
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Alnylam Pharmaceuticals Inc.
$22
CALLIDITAS THERAPEUTICS US INC.
$22
Novartis Pharmaceuticals Corporation
$20
Cardinal Health 200, LLC
$17
Amicus Therapeutics, Inc.
$16
Daiichi Sankyo Inc.
$15
Arrow International, Inc.
$12
Top 3 companies account for 47.8% of total payments
Associated products mentioned in payments ›
(6578) Visions 018 · ACTHAR · ACUSEAL Vascular Graft · AURYON LASER SYSTEM 100-120 VAC · Auryxia · BENLYSTA · CLOSUREFAST · COVERA · CROSSER · CRYSVITA · Catheter - Turnpike · ClosureFast · DefenCath · Diamondback Peripheral · ELLIPSYS VASCULAR ACCESS SYSTEM · FARXIGA · FLEXITOUCH · FLUENCY · Flexitouch Plus · Fluency · Fluency Endovascular Stent Graft · GALAFOLD · GORE VIABAHN VBX Balloon Expandable Endo · IN.PACT Admiral · INJECTAFER · INVOKANA · Image Guided Therapy Devices _ Peripheral · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · LUTONIX · Lympha Press Optimal Plus(US) BT · MynxGrip Vascular Closure Device · OXLUMO · PROCLAIM · Parsabiv · Peripheral Orbital Atherectomy System · Peritoneal Dialysis Systems · RAYALDEE · Rayaldee · SAMSCA · SYNAGIS · System One · TARPEYO · TAVNEOS · Tavneos · ULTOMIRIS · VENASEAL · VIABAHN Endoprosthesis · VIABAHN Endoprosthesis with PROPATEN Bioactive Surface · Vafseo · Varithena Administration Pack · Velphoro · Veltassa · VenaSeal · WAVELINQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (78%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in TX.

Equivalent to $17,614 per 100 Medicare services performed
Looking for a internal medicine in Fort Worth?
Compare internal medicines in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse internal medicines nearby

Geographic Context

Internal Medicines within 10 mi
905
Per 100K population
42.4
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Balamuthusamy is a mixed practice specialist, with above-average Medicare volume (top 15% in TX), and high industry engagement (speaking/promotional, top 0%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Balamuthusamy experienced with home dialysis services per month (20 years or older)?
Based on Medicare claims data, Dr. Balamuthusamy performed 214 home dialysis services per month (20 years or older) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Balamuthusamy receive payments from pharmaceutical companies?
Yes. Dr. Balamuthusamy received a total of $416,399 from 45 companies across 596 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Balamuthusamy's costs compare to other internal medicines in Fort Worth?
Dr. Balamuthusamy's average Medicare payment per service is $179. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Balamuthusamy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →